ASN
GTBP icon

Advisory Services Network’s GT Biopharma GTBP Stock Holding History

Advisory Services Network’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$7.85K – 4836
2025
Q4 		$7.85K Buy
+400
New +$7.1K ﹤0.01% 1800
2024
Q1 		– Hold
0
– -$38 – 2362
2023
Q4 		– Hold
0
– – – 3820
2023
Q2 		– Hold
0
– -$83 – 2344
2023
Q1 		– Hold
0
– – – 3910
2022
Q4 		– Hold
0
– – – 3888
2021
Q3 		– Hold
0
– -$2K – 2169
2021
Q2 		– Hold
0
– – – 3316

Other funds holding GTBP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
I
INVST Indianapolis, Indiana $1.03B AUM 29.49% 1-Year Est. Return

Advisory Services Network's GTBP Position: Q1 2026 in Review

Advisory Services Network sold out of GT Biopharma (GTBP) in Q1 2026, closing a stake of 400 shares — an estimated $7.85K sold.

Advisory Services Network first reported a position in GTBP in Q4 2025 and held it in 1 quarter. The position peaked at $7.85K in Q4 2025. 40 funds tracked by Wall St. Rank hold GTBP as of Q1 2026.

  • Advisory Services Network reported no remaining GT Biopharma position as of Q1 2026 after selling out during the quarter.
  • Advisory Services Network sold 400 GT Biopharma shares in Q1 2026, an estimated $7.85K.
  • Advisory Services Network first reported a position in GT Biopharma in Q4 2025 and held it in 1 quarter.
  • Advisory Services Network's GT Biopharma position peaked at $7.85K in Q4 2025.
  • 40 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.